|Therapeutic Area||Formulary Choices||Cost for 28|
(unless otherwise stated)
|Rationale for decision / comments|
|Related guidance: CG177 Osteoarthritis: Care and management in adults Feb 2014
Low back pain and sciatica in over 16s:assessment and management (NG59 November 2016)
Rheumatoid arthritis in adults:management (CG79 Dec 2015)
Headaches in over 12s:diagnosis and management (CG150 Nov 2015)
Neuropathic pain in adults:pharmacological management on non-specialist settings (CG173 Nov 2013) See next chapter
|Use this Option Grid™ decision aid to help you and your healthcare professional decide which tablets you may like to take for long-term and flare-up pain of the muscles, ligaments, or soft tissue|
|Avoid soluble formulations of Paracetamol and Co-Codamol because of high sodium content (the equivalent of up to 9g of salt per day at full dose) which may contribute to or exacerbate hypertension or heart failure. These products are also more expensive, for example paracetamol soluble tablets 500mg are £9.21 for 100, and for patients with swallowing difficulties a suspension is a more cost effective and often more palatable option.|
|Medication Overuse Headache All medications for treating headache can cause MOH in patients with a pre-existing primary headache disorder, even if taking medicines for pain other than headache. Mean onest 1.7 years (triptans) to 4.8 years (analgesics)|
|Prescribing duration of Controlled Drugs. Maximum duration per prescription should be no longer than thirty days
Oral dosage forms in the main, particularly morphine MR which, at bd dose, should not exceed 60 tablets/capsules.
Patches are a particular problem.
Fentanyl- 72 hour (three day) patches so 10 patches (2x5) per month limit
Buprenorphine 5, 10 and 20mg -7 day patches so one pack of 4 per month limit
Buprenorphine 35, 52.5 and 70mg-change twice a week so 8 patches (2x4) per month limit
|Paracetamol - suitable for self-care|
Paracetamol oral suspension 250mg/5ml S/F
|500mg tablets: £2.28 (100)|
|First choice drug in acute and chronic pain. If treatment is not effective check that adequate dose is being used (i.e. 1g QDS) before adding other options. Available OTC.
Paracetamol may be considered an option for treating agitation in people with dementia where pain may be a factor. Husebo et al. (2011) Br Med J 343: d4065; Husebo, Ballard, & Aarsland (2011) Int J Ger Psych 26: 1012-1018.
Avoid 500mg/5ml solution or susp as very expensive (£18 or £30 per 200mls)
|Weak opioid analgesics||The CCG strongly recommends that prescribers discuss the risk of addiction when initiating new patients on any opioid containing medication and also on review. This discussion should be recorded in the patient notes. Just three days of codeine or dihydrocodeine medicines can lead to addiction.
Co-codamol 8/500, 15/500 and co-dydramol are non-formulary. It is recommended that standard paracetamol treatment be topped up with codeine 15mg tablets at breakthrough.
The Faculty of Pain at The Royal College of Anaethestists states some important principles around opiate prescribing:
* Opioids are very good an analgesic for ACUTE PAIN AT THE END OF LIFE but there is little evidence that they are helpful for long term pain.
* A small proportion of people may obtain good pain relief with opioids in the long term if the dose can be kept low and especially if their use is intermittent (however it is difficult to identify these people at the point of opioid initiation)
* The risk of harm increases substantially at doses above an oral morphine equivalent of 120mg/day, but there is no increased benefit.
* If a patient is using opiods but is still in pain, the opioids are not effective and should be discontinued, even if no other treatment is available.
* Chronic pain is very complex and if patients have refractory and disabling symptoms, particularly if they on high opioid doses, a very detailed assessment of the many emotional influences on their pain experience is essential.
For more information see Opioids Aware: A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain
|Codeine 30mg x 8/day provides 240mg codeine equivalent to Morphine 30mg||Codeine||15mg tablets: £0.96|
30mg tablets: £1.16
60mg tablets: £1.83
|Note that around 10% of the caucasian population lack the enzyme to metabolize Codeine so derive little benefit from it, but still suffer the side effects
Prescribing Paracetamol and Codeine separately enables more appropriate dose titration and enables patients to take more control of their own pain management, e.g. taking Paracetamol regularly and adding Codeine as required. Codeine alone is not considered a particularly effective analgesic.
|50mg capsules: £2.83 (100)||Tramadol may be considered as an alternative to codeine where its efficacy or tolerability is poor. MHRA advise short-term or intermittent treatment; caution where history of addiction or seizure
Tramadol may be most effective when given with full therapeutic doses of Paracetamol (i.e.Do NOT prescribe as Tramacet® as it only contains 375mg paracetamol).
Tramadol is associated with Serotonin syndrome when taken in conjunction with other serotonergic medications such as fentanyl, SSRIs, SNRIs, TCAs, MAOIs
as Tradorec XL®
|100mg tablets: £6.94 (60)|
150mg tablets: £10.39 (60)
200mg tablets: £14.19 (60)
100mg tablets: £14.10 (30)
200mg tablets: £14.98 (30)
300mg tablets: £22.47 (30)
|For patients with long term chronic pain responsive to tramadol but who suffer significant side effects from the immediate release capsules a modified release product may be prescribed.
For patients suffering long term chronic night time pain and pain on early waking, Tradorec XL® is a formulary option.
Maintenance dose for majority of patients is 200mg IN THE EVENING
Co-codamol 30/500 x 8/day provides 240mg codeine equivalent to Morphine 30mg
|Combination formulations that include tramadol as one of the ingredients (e.g. Tramacet®) are non-formulary.|
|The CCG strongly recommends that prescribers discuss the risk of addiction when initiating new patients on any opioid containing medication and also on review. This discussion should be recorded in the patient notes. Just three days of codeine or dihydrocodeine medicines can lead to addiction.|
|30/500mg tablets: £2.83(100)|
30/500mg capsules £3.88 (100)
|Co-Codamol 30/500 is a potent analgesic carrying the full range of opioid side effects e.g. constipation and sedation, requiring particular care in the elderly – see BNF warning.
Prescribe as separate components if possible.
|Management of opioid overdosage may require use of Naloxone: refer to Chapter 15 of the BNF|
|Strong opioid analgesics||For non-cancer pain, strong opioids should be considered only when they are used as part of a programme of supported rehabilitation, with the goal of helping patients to manage pain-related disability. There is no evidence of superior clinical analgesic effect of other opioids over morphine|
|10mg/5ml solution: £5.45 (300ml||Use oral solution for initial dose titration and breakthrough pain. Doses not to be given at intervals of less than one hour.
Typical time to onset of therapeutic level –
Oral morphine solution: 20 – 30 minutes
Oxycodone solution: 60 minutes
Morphine tablets: 90 minutes
Oramorph 10mg/5ml is a schedule 5 medicine, unlike its equivalent strength of tablets or capsules which are schedule 2. Oramorph 10mg/5ml is not subject to the same rules of prescribing, recording and storage as the solid dose forms and is often prescribed and used with less care. Oramorph used for breakthrough pain at prn dose is often overdosed, so please prescribe with the same caution as solid forms. Also, do not confuse with Oramorph Conc which is 100mg/5ml (30ml and 120ml bottles) which is designed to be measured with the accompanying dropper.
|Modified release capsules as Zomorph®||10mg capsules: £3.47 (60)|
30mg capsules: £8.30 (60)
60mg capsules: £16.20 (60)
100mg capsules: £21.80 (60)
200mg capsules: £43.60 (60)
|Zomorph® is the recommended modified-release morphine formulation.
Subject to CD regulations.
Capsules can be opened and sprinkled on semi-solid food (e.g. yoghurt) or given in water via NG tube.
|Modified release tablets as Morphgesic SR®||10mg tablets: £3.85 (60)|
30mg tablets: £9.24 (60)
60mg tablets: £18.04 (60)
100mg tablets: £28.54 (60)
|Morphgesic SR® is the recommended modified-release morphine tablet formulation.
Subject to CD regulations.
|Second-line:||Fentanyl||Fentanyl is only included for patients where morphine is contra-indicated or not tolerated or where there is specific need for a non-oral route. For non-cancer pain, 75mcg/hour should be the maximum dose, if ineffective other causes for lack of response should be considered (eg. Primary anxiety or unrealistic expectations of analgesia from patch).
Fentanyl is associated with Serotonin syndrome when taken in conjunction with other serotonergic medications such as tramadol, SSRIs, SNRIs, TCAs, MAOIs
|12mcg / hour: £7.52 (5) |
25mcg / hour: £10.76 (5)
50mcg / hour: £20.12 (5)
75mcg / hour: £28.06 (5)
100mcg / hour: £34.59 (5)
|See MHRA DSU Vol.2 Issue 2 (Sep-08): Fentanyl patches: serious and fatal overdose from dosing errors, accidental exposure, and inappropriate use.
Increases in body temperature and external heat sources may lead to potentially fatal rises in serum fentanyl levels.
|as Fencino®||12mcg / hour: £8.46(5) |
25mcg / hour: £12.10 (5)
50mcg / hour: £22.62 (5)
75mcg / hour: £31.54 (5)
100mcg / hour: £38.88 (5)
|as Mezolar®||12mcg / hour: £7.53(5) |
25mcg / hour: £10.77 (5)
37.5mcg / hour: £15.46 (5)
50mcg / hour: £20.13 (5)
75mcg / hour: £28.07
100mcg / hour: £34.60
|Buprenorphine patches||Like other transdermal products, increases in body temperature (eg after bathing) and external heat sources may lead to increased serum levels of active drug.|
|as Reletrans®||5mcg/hr : £7.92(4)|
10mcg/hr: £14.20 (4)
15mcg/hr: £22.12 (4)
|Equivalent to Butrans® but considerably cheaper.|
|as Butec®||5mcg/hr : £7.92 (4)|
10mcg/hr: £14.20 (4)
15mcg/hr: £22.12 (4)
|Equivalent to Butrans® but cheaper.|
|as Hapoctasin®||35mcg/hr : £9.48 (4)|
52.5mcg/hr: £14.23 (4)
70mcg/hr: £18.96 (4)
|As an option for patients with moderate to severe cancer pain for whom fentanyl may be too potent.
Note: Hapoctasin® are 72 hour patches the same as fentanyl. Transtec® have the same rate of drug delivery as Hapoctasin® but are 96 hour patches. Table of approximate dose equivalents from the British Pain Society
|as Relevtec®||35mcg/hr : £11.06 (4)|
52.5mcg/hr: £16.60 (4)
70mcg/hr: £22.12 (4)
|Reveltec should be replaced after 96 hours (4 days) at latest. For convenience of use the transdermal patch can be changed twice a week at regular intervals e.g Monday morning and Thursday evening|
|Third-line:||Oxycodone||Oxycodone is included only for patients where morphine is contra-indicated or not tolerated. Available data does not provide any evidence of oxycodone‟s superiority to morphine.|
|The CQC have issued guidance on prescribing, supply and administration:
Safer Use of Controlled Drugs – Preventing Harm From Oral Oxycodone Medicines
|Instant release |
|5mg capsules £6.86 (56)
10mg capsules £13.72 (56)
20mg capsules £27.43 (56)
5mg/5ml oral solution: £8.25. (250ml)
10mg/ml oral solution, £39.64(120ml) (CONCENTRATE-note strength)
|Modified release |
|5mg tablets: £6.26 (28) |
10mg tablets: £12.52 (56)
15mg tablets: £19.06 (56)
20mg tablets: £25.04 (56)
30mg tablets: £38.11 (56)
40mg tablets: £50.09 (56)
60mg tablets: £76.24 (56)
80mg tablets: £100.19 (56)
120mg tablets: £152.52 (56)
|Targinact® is non-formulary: not a cost-effective use of NHS resources. No long-term data, no comparison with other opioids with/without regular laxatives|
|Fourth-line:||Tapentadol||Fourth-line strong opioid analgesic: Approved for relief of moderate to severe pain in adults as an alternative to oxycodone|
|Instant release||50mg tablets: £12.46 (28)|
75mg tablets: £18.68 (28)
|Note: instant release product only licensed for acute pain|
|Modified release||50mg tablets: £12.46 (28) |
100mg tablets: £49.82 (56)
150mg tablets: £74.73 (56)
200mg tablets: £99.64 (56)
250mg tablets: £124.55 (56)
|Note: slow release preparation is only licensed for chronic pain.
Procedures should be in place to prevent inadvertent prescribing errors
Table of approximate dose equivalents from British Pain Society